Factors guiding NSAID formulary inclusion

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.254, 2000-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chairman of the Joint Formulary Committee, British National Formulary

By Kendall Martin

Clinical Medicine, Vol. 9, Iss. 4, 2009-08 ,pp. : 349-352

Royal College Of Physicians

Access to resources Recommend Favorite

Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3428-3434

Blackwell Publishing

Access to resources Recommend Favorite

NSAID Acyl Glucuronides and Enteropathy

Current Drug Metabolism, Vol. 12, Iss. 3, 2011-03 ,pp. : 245-252

Bentham Science Publishers

Access to resources Recommend Favorite

Formulary Management of Proton Pump Inhibitors

By Byrne M.F. Murray F.E.

PharmacoEconomics, Vol. 16, Iss. 3, 1999-09 ,pp. : 225-246

Adis International

Access to resources Recommend Favorite

Against formulary restriction of SSRIs for depression

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite